Synergy Biomedical
  • ABOUT US
    • Mission/Background
    • Management
    • Quality System
    • Press Releases
  • PRODUCTS
    • BioSphere® PUTTY
    • BioSphere® MIS II
    • BioSphere® Flex
    • BioSphere® FLEX SP
    • BioSphere® Flex SP Extremities
  • Technology
    • Bioactive Glass Properties
    • Evolution of Bioactive Glass
    • The BioSphere® Advantage >
      • BioSphere Particles
      • Bioactive Glass Content
      • Biosphere Putty Handling
    • In Vivo Bone Healing
    • Applications
  • Surgeons
  • Distributors
  • Contact Us

Bioactive Glass Properties


Bioactive Glass Background
  • The 45S5 formulation of bioactive glass has been the primary material used in today's bioactive glass bone graft products (45% SiO2, 24.5% CaO, 24.5% Na2O, and 6% P2O5).

  • When implanted, 45S5 bioactive glass undergoes a dissolution process that releases ions from the glass.  45S5 bioactive glass particles are fully resorbed and replaced by bone within approximately 9-12 months.

  • The dissolution process is governed by the shape and size of the particle.  Due to a higher surface area, smaller particles will dissolve faster than larger particles.  In addition, spherical particles will have more reproducible ion release.
Picture
Standard bioactive glass is ground and sieved into
a broad particle size range of irregular particles.

Bioactive Properties
  • The bioactive properties of 45S5 glass are due to the ability of the material to form a bone-like mineral layer on its surface (hydroxy-carbano-apatite - HCA). [1]  As the bioactive glass particles begins to dissolve in vivo, the ions released from the glass combine with local ions to form an HCA coating on the surface.

  • Due to the similarity of the HCA layer to bone mineral, the coating provides an optimal surface for new bone formation and results in a chemical bond between the bioactive glass particles and the surrounding bone.
Picture

Cellular Effects
  • During the dissolution of 45S5 bioactive glass, a variety of ions are released from the material (silica, calcium, phosphate, and sodium ions).

  • In vitro testing of 45S5 bioactive glass has shown that the dissolution ions positively affect cells involved in bone formation. [2,3]  
Picture

References
  1. Hench l.  "Bioactive Materials:  The Potential for Tissue Regeneration."  J. Biomed. Mat. Res.41: 511-518 (1998).
  2. Xynos I.  "Gene-expression profiling human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution."  J. Biomed. Mat. Res. 55:151-157 (2001).
  3. Bosetti M.  "The effect of bioactive glasses on bone marrow stromal cells differentiation."  Biomaterials.  26:3873-3879 (2005).
©2022 Synergy Biomedical, LLC
565 E. Swedesford Rd • Suite 310 • Wayne, PA 19087 • Main Office: 484.902.8141 • Fax: 484.902.8179 • Email: [email protected]
DISCLAIMER  |  PRIVACY POLICY  |  TERMS & CONDITIONS  |  SITEMAP
  • ABOUT US
    • Mission/Background
    • Management
    • Quality System
    • Press Releases
  • PRODUCTS
    • BioSphere® PUTTY
    • BioSphere® MIS II
    • BioSphere® Flex
    • BioSphere® FLEX SP
    • BioSphere® Flex SP Extremities
  • Technology
    • Bioactive Glass Properties
    • Evolution of Bioactive Glass
    • The BioSphere® Advantage >
      • BioSphere Particles
      • Bioactive Glass Content
      • Biosphere Putty Handling
    • In Vivo Bone Healing
    • Applications
  • Surgeons
  • Distributors
  • Contact Us